Covishield Vaccine AstraZeneca Faces Concerns Over Vaccine Side Effects: “Sympathy Goes Out… admin, April 30, 2024 The World Health Organisation (WHO) has endorsed the safety and efficacy of the Covishield vaccine, developed by the Serum Institute of India and marketed under this name in India. The vaccine, based on a viral vector platform, uses a modified chimpanzee adenovirus to transport the COVID-19 spike protein into human… Continue Reading
Covishield Vaccine AstraZeneca acknowledges rare side-effect of Covishield vaccine. Is there cause for concern? admin, April 30, 2024 TTS – a blood clot disorder — is a rare side effect of AstraZeneca’s Covid vaccine. This comes after reports said that AstraZeneca has for the first time accepted in court documents that its vaccine, developed in partnership with Oxford University, can raise the risk of a rare and serious… Continue Reading
Covishield Vaccine AstraZeneca Admits Covishield Can Cause Rare Side Effect in Big U-Turn admin, April 29, 2024 AstraZeneca is currently facing a class action lawsuit in the UK regarding its Covishield vaccine, which can lead to rare cases of blood clots and a low platelet count, as stated in the company’s court documents. The vaccine, developed by AstraZeneca and Oxford University, was produced by the Serum Institute… Continue Reading